CD274 and prostate carcinoma: Castration-resistant prostate cancer (CRPC) cells highly express PD-L1, and the cytotoxicity of NK cells against hypoxia-induced CRPC cells was enhanced by the inhibition of JAK1, STAT3 (upstream regulators of PD-L1) in combination with PD-L1 antibody [81].